发明名称 |
USE OF CANNABIDIOL IN THE TREATMENT OF EPILEPSY |
摘要 |
The present disclosurerelates to the use of cannabidiol (CBD) in the treatment of absence seizures. In particular, the disclosure relates to the use of CBD for reducing absence seizures in patients suffering withetiologies that include: Lennox-Gastaut Syndrome; Tuberous Sclerosis Complex; Dravet Syndrome; Doose Syndrome; CDKL5; Dup15q;, Jeavons syndrome; Myoclonic Absence Epilepsy;Neuronal ceroid lipofuscinoses(NCL) and brain abnormalities. The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs). |
申请公布号 |
WO2015193668(A1) |
申请公布日期 |
2015.12.23 |
申请号 |
WO2015GB51776 |
申请日期 |
2015.06.17 |
申请人 |
GW PHARMA LIMITED |
发明人 |
GUY, GEOFFREY;WRIGHT, STEPHEN;MEAD, ALICE;CHEETHAM, EMMA;DEVINSKY, ORRIN;SCHILLER, DOMINIC |
分类号 |
A61K31/05;A61K31/195;A61K31/20;A61K31/27;A61K31/352;A61K31/4015;A61K31/4166;A61K31/423;A61K31/496;A61K31/53;A61K31/551;A61K31/5513;A61K31/5517;A61K31/7048;A61P25/10 |
主分类号 |
A61K31/05 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|